Maravai LifeSciences Inc...
(MRVI)
undefined
undefined%
At close: undefined
5.59
-1.32%
After-hours Dec 13, 2024, 06:51 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -119.03M | 490.66M | 469.25M | 78.82M | -5.20M | -16.91M |
| Depreciation & Amortization | 48.78M | 38.10M | 24.75M | 25.84M | 24.08M | 22.35M |
| Stock-Based Compensation | 34.59M | 18.67M | 10.46M | 24.63M | 1.68M | 2.12M |
| Other Working Capital | 7.52M | -30.69M | -85.34M | 86.96M | 1.60M | -13.13M |
| Other Non-Cash Items | -690.90M | -8.70M | -6.16M | -7.52M | 2.42M | 7.79M |
| Deferred Income Tax | 754.94M | 42.32M | 46.90M | -5.46M | -1.16M | 317.00K |
| Change in Working Capital | 97.84M | -45.08M | -176.63M | 35.89M | 2.29M | -15.84M |
| Operating Cash Flow | 126.22M | 535.98M | 368.57M | 152.19M | 24.11M | -186.00K |
| Capital Expenditures | -65.55M | -17.09M | -14.85M | -25.41M | -17.15M | -3.61M |
| Acquisitions | -69.62M | -238.35M | 119.96M | -3.02M | - | 160.00K |
| Purchase of Investments | - | - | - | - | - | - |
| Sales Maturities Of Investments | - | - | - | - | - | - |
| Other Investing Acitivies | 12.87M | -12.17M | 548.00K | 34.50M | - | 160.00K |
| Investing Cash Flow | -122.31M | -267.61M | 105.66M | 6.07M | -17.15M | -3.45M |
| Debt Repayment | -5.77M | -5.44M | -6.00M | 196.92M | -2.64M | 55.43M |
| Common Stock Repurchased | -20.00K | - | - | -1.46B | -227.00K | -9.00K |
| Dividend Paid | - | - | - | - | - | -52.06M |
| Other Financial Acitivies | -55.30M | -182.06M | -153.05M | -444.66M | -1.30M | -12.53M |
| Financial Cash Flow | -61.09M | -187.50M | -159.05M | 53.21M | -4.17M | -9.17M |
| Net Cash Flow | -57.18M | 80.87M | 315.09M | 211.48M | 2.83M | -12.87M |
| Free Cash Flow | 60.67M | 518.89M | 353.72M | 126.78M | 6.97M | -3.80M |